• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Division of Supply Chain Integrity Warning Letters and Notice of Violation Letters to Website Operators

These Warning Letters and Notice of Violation Letters warn website operators that they may be engaged in illegal activities and inform them of the laws that govern prescription drug sales.

 
This page only covers letters issued by the CDER Office of Compliance Office of Drug Security, Integrity, and Recalls and the Office of Unapproved Drugs and Labeling Compliance.
 
If you wish to obtain additional information on the current status of an issue in a particular warning letter or notice of violation on this website, please contact the FDA or the recipient of the letter directly. Inquires to FDA should be sent to:
 
Food and Drug Administration
Division of Freedom of Information
Office of the Executive Secretariat, OC
12420 Parklawn Drive, ELEM-1029
Rockville, MD 20587
 
Instructions for how to submit an FOI request can be found on the FDA FOI page.
 

 
 
Return to Page: Division of Supply Chain Integrity